GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AegirBio AB (GREY:AEGBF) » Definitions » Days Sales Outstanding

AegirBio AB (AegirBio AB) Days Sales Outstanding : 0.00 (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is AegirBio AB Days Sales Outstanding?

AegirBio AB's average Accounts Receivable for the three months ended in Mar. 2024 was $0.53 Mil. AegirBio AB's Revenue for the three months ended in Mar. 2024 was $0.00 Mil.

The historical rank and industry rank for AegirBio AB's Days Sales Outstanding or its related term are showing as below:

AEGBF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 193.6   Med: 599.85   Max: 54037.26
Current: 54037.26

During the past 4 years, AegirBio AB's highest Days Sales Outstanding was 54037.26. The lowest was 193.60. And the median was 599.85.

AEGBF's Days Sales Outstanding is ranked worse than
99.63% of 812 companies
in the Medical Devices & Instruments industry
Industry Median: 64.77 vs AEGBF: 54037.26

AegirBio AB's Days Sales Outstanding declined from Dec. 2022 (31,161.88) to Mar. 2024 (0.00).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.


AegirBio AB Days Sales Outstanding Historical Data

The historical data trend for AegirBio AB's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AegirBio AB Days Sales Outstanding Chart

AegirBio AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Days Sales Outstanding
- - 193.62 1,115.03

AegirBio AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31,161.88 7,446.00 - 12,470.83 -

Competitive Comparison of AegirBio AB's Days Sales Outstanding

For the Medical Devices subindustry, AegirBio AB's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AegirBio AB's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AegirBio AB's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where AegirBio AB's Days Sales Outstanding falls into.



AegirBio AB Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

AegirBio AB's Days Sales Outstanding for the fiscal year that ended in Dec. 2022 is calculated as

Days Sales Outstanding (A: Dec. 2022 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2021 ) + Accounts Receivable (A: Dec. 2022 )) / count ) / Revenue (A: Dec. 2022 )*Days in Period
=( (0.775 + 0.227) / 2 ) / 0.164*365
=0.501 / 0.164*365
=1,115.03

AegirBio AB's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding (Q: Mar. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )*Days in Period
=( (0.416 + 0.65) / 2 ) / 0*365 / 4
=0.533 / 0*365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AegirBio AB  (GREY:AEGBF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


AegirBio AB Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of AegirBio AB's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


AegirBio AB (AegirBio AB) Business Description

Traded in Other Exchanges
Address
Scheelevagen 27, Lund, SWE, SE-223 63
AegirBio AB is a Swedish diagnostic company that offers tests to monitor and optimize the dosage of biological drugs via its patented technology platform. The company's products include Monator - drug monitoring of tysabri in MS, Veritope, and Magniareader.

AegirBio AB (AegirBio AB) Headlines

No Headlines